Teladoc Inc (NYSE:TDOC) – Equities research analysts at KeyCorp increased their FY2017 earnings per share estimates for shares of Teladoc in a note issued to investors on Monday. KeyCorp analyst D. Hooker now expects that the health services provider will earn ($1.46) per share for the year, up from their prior estimate of ($1.56). KeyCorp currently has a “Buy” rating and a $41.00 target price on the stock. KeyCorp also issued estimates for Teladoc’s Q4 2017 earnings at ($0.31) EPS, Q1 2018 earnings at ($0.36) EPS, Q2 2018 earnings at ($0.19) EPS, Q3 2018 earnings at ($0.18) EPS, Q4 2018 earnings at ($0.20) EPS, FY2018 earnings at ($0.93) EPS and FY2019 earnings at ($0.75) EPS.
Teladoc (NYSE:TDOC) last announced its earnings results on Wednesday, November 1st. The health services provider reported ($0.55) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.30) by ($0.25). The firm had revenue of $68.70 million during the quarter, compared to analyst estimates of $67.53 million. Teladoc had a negative net margin of 45.64% and a negative return on equity of 29.70%. The firm’s revenue for the quarter was up 112.0% compared to the same quarter last year. During the same period last year, the company earned ($0.33) earnings per share.
Shares of Teladoc (TDOC) opened at $33.20 on Thursday. The stock has a market capitalization of $2,010.00 and a PE ratio of -22.90. The company has a debt-to-equity ratio of 0.83, a current ratio of 5.08 and a quick ratio of 5.08. Teladoc has a 1 year low of $15.65 and a 1 year high of $38.40.
In other Teladoc news, CEO Jason N. Gorevic sold 100,000 shares of the stock in a transaction that occurred on Monday, December 4th. The stock was sold at an average price of $32.99, for a total transaction of $3,299,000.00. Following the completion of the sale, the chief executive officer now directly owns 718,261 shares of the company’s stock, valued at approximately $23,695,430.39. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, VP Mark Hirschhorn sold 35,000 shares of the stock in a transaction that occurred on Tuesday, October 17th. The stock was sold at an average price of $32.84, for a total value of $1,149,400.00. Following the sale, the vice president now directly owns 20,887 shares of the company’s stock, valued at $685,929.08. The disclosure for this sale can be found here. Insiders have sold a total of 210,000 shares of company stock valued at $6,889,350 over the last ninety days. 4.47% of the stock is owned by insiders.
Several hedge funds have recently modified their holdings of the company. Iguana Healthcare Management LLC purchased a new position in shares of Teladoc during the 3rd quarter worth approximately $1,160,000. Neuberger Berman Group LLC raised its stake in shares of Teladoc by 53.4% during the 3rd quarter. Neuberger Berman Group LLC now owns 25,785 shares of the health services provider’s stock worth $855,000 after buying an additional 8,971 shares in the last quarter. California Public Employees Retirement System raised its stake in shares of Teladoc by 52.1% during the 3rd quarter. California Public Employees Retirement System now owns 11,409 shares of the health services provider’s stock worth $378,000 after buying an additional 3,909 shares in the last quarter. Bamco Inc. NY raised its stake in shares of Teladoc by 751.9% during the 3rd quarter. Bamco Inc. NY now owns 1,455,900 shares of the health services provider’s stock worth $48,263,000 after buying an additional 1,285,000 shares in the last quarter. Finally, Granahan Investment Management Inc. MA purchased a new position in shares of Teladoc during the 3rd quarter worth approximately $14,569,000.
ILLEGAL ACTIVITY NOTICE: “FY2017 Earnings Estimate for Teladoc Inc (TDOC) Issued By KeyCorp” was originally reported by Community Financial News and is owned by of Community Financial News. If you are viewing this piece of content on another publication, it was illegally stolen and republished in violation of international trademark and copyright legislation. The correct version of this piece of content can be accessed at https://www.com-unik.info/2018/01/12/fy2017-earnings-estimate-for-teladoc-inc-tdoc-issued-by-keycorp.html.
Teladoc, Inc is a telehealth company. The Company offers telehealth platform, delivering on-demand healthcare anytime, anywhere, through mobile devices, the Internet, video and phone. The Company’s solution connects its Members, with its over 3,000 board certified physicians and behavioral health professionals treating a range of conditions and cases from acute diagnoses, such as upper respiratory infection, urinary tract infection and sinusitis to dermatological conditions, anxiety and smoking cessation.
Receive News & Ratings for Teladoc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc and related companies with MarketBeat.com's FREE daily email newsletter.